Breast Cancer Second Opinion: What Oncologists Review

You have a diagnosis and a treatment plan. Before you commit to it, consider asking a different specialist to review everything from the start.

A second opinion for breast cancer is a recognized, routine step that oncologists at major cancer centers actively encourage. There are good reasons: breast cancer pathology involves judgment, receptor testing can vary between labs, and choosing between breast-conserving surgery and mastectomy isn't straightforward.

This article explains what a surgical oncologist and a medical oncologist each look at when reviewing your case. Understanding what they check will help you decide if a second opinion is right for you and how to prepare for one.

What Is a Breast Cancer Second Opinion?

A breast cancer second opinion is a review of your diagnosis and treatment plan by a specialist who wasn't involved in your original care. A surgical oncologist assesses your surgery options. A medical oncologist reviews your systemic treatment - chemotherapy, hormone therapy, or targeted therapy. Many centers offer both reviews online.

How Often Does a Second Opinion Change the Plan?

More often than most patients expect.

Researchers studied breast cancer patients referred to a National Cancer Institute (NCI)-designated cancer center. They found that when pathologists reviewed the slides again, many patients got different surgery or treatment recommendations. The full research is available at PubMed Central.

A separate analysis of 205 breast cancer biopsy specimens found that pathology reports changed in approximately 25% of reviewed cases. Major changes - those affecting staging or treatment selection - happened in roughly 16% of specimens. Minor but clinically relevant changes happened in about 9%.

A third study found that clinically significant discrepancies appear in more than 10% of breast pathology second reviews, which affect prognosis and surgical planning.

These numbers show that breast cancer pathology involves judgment calls at every step. A second expert review can catch important details. For a broader look at what tends to shift when a plan is reconsidered, see what changes after a second opinion in cancer care.

What a Surgical Oncologist Reviews

A surgical oncologist focuses on the physical tumor - its size, location, and how to remove it. Here's what they examine when reviewing your case.

The Pathology Report and Original Biopsy Slides

The pathology report describes the cancer's type - for example, invasive ductal carcinoma versus invasive lobular carcinoma - and its grade. A second surgical oncologist may request the original glass slides, not just the typed report, and have them re-read by a breast-specialized pathologist at their center. This re-reading is where discrepancies in tumor grade, subtype, and invasion status most often come to light.

Tumor Size and Surgical Margins

Margin status describes whether cancer cells reach the edge of the removed tissue sample. It directly affects whether additional surgery is needed. A second surgeon may interpret margin data differently, or may be aware of newer margin-assessment approaches that could change the recommended procedure.

Lumpectomy Versus Mastectomy

This is the surgical question patients most often want a second view on. According to the National Cancer Institute, for many patients with early-stage disease, long-term survival outcomes between lumpectomy with radiation and mastectomy are similar. The right choice depends on tumor size relative to breast size, tumor location, genetic factors such as BRCA status, and patient preference.

A second surgical oncologist may see things differently - for example, whether a specific tumor location makes breast-conserving surgery possible with good results, or whether your first surgeon missed reconstruction options. For a detailed look at the full range of surgical approaches, see breast cancer surgery options: lumpectomy, mastectomy, and robotic-assisted approaches. If you're weighing surgical technique, you may also want to read what robotic and minimally-invasive breast surgery actually involves, a specialist resource that explains how these approaches differ in practice.

Lymph Node Involvement

Whether cancer has spread to nearby lymph nodes affects both surgical planning and the systemic treatment that follows. A second surgeon reviews sentinel lymph node biopsy results and may have a different view on whether a full axillary lymph node dissection is needed, or whether a more limited approach is appropriate for your case.

Genetic Testing Referral

A breast cancer second opinion often includes a review of whether genetic counseling has been discussed. Inherited gene variants - including BRCA1 and BRCA2 - may affect the choice between lumpectomy and mastectomy, and whether the opposite breast should also be evaluated. If this conversation has not happened with your first team, a second surgical oncologist will often raise it.

What a Medical Oncologist Reviews

While the surgical oncologist focuses on removing the tumor, the medical oncologist focuses on treating any cancer cells that may have traveled beyond the breast. Their review centers on your tumor's biology and what systemic therapy your case calls for.

Hormone Receptor Status: ER and PR

Most breast cancers express receptors for estrogen (ER), progesterone (PR), or both. The percentage of cells that test positive - reported as an Allred score or H-score depending on the lab - affects which hormone-blocking therapies are considered. Labs can differ in how they measure and report these levels. A second medical oncologist may interpret a borderline result differently, or may request the test be repeated at their own institution's lab.

HER2 Status

Human epidermal growth factor receptor 2 (HER2) amplification enables targeted therapies designed for HER2-positive disease. HER2 testing uses immunohistochemistry (IHC) and, in borderline cases, in-situ hybridization (ISH). Discrepancies in HER2 interpretation between labs have been documented in research. A second pathology review at a high-volume center may resolve a borderline result either way - which affects your treatment plan.

Genomic Testing Results

For hormone receptor-positive, HER2-negative early-stage breast cancer, genomic tests such as Oncotype DX or MammaPrint estimate the chance of cancer returning and help determine whether chemotherapy will help you. A second medical oncologist may interpret a score differently, or may recommend a test that has not yet been ordered. If molecular testing has not been fully discussed with your care team, do you need a second opinion on molecular testing gives a plain-English overview of how these tests work and what they measure.

Stage and Systemic Treatment Planning

The medical oncologist reviews your full imaging history - mammograms, ultrasound, breast MRI, and any staging scans - to confirm the stage. They then assess your full treatment plan: whether treatment before surgery (called neoadjuvant therapy) might improve outcomes, how therapies should be sequenced, and whether targeted therapies or clinical trials fit your case.

Clinical Trial Eligibility

A second medical oncologist at a high-volume center may know about trials your local team doesn't have access to, or may determine that you qualify for studies you haven't heard about.

When Is a Breast Cancer Second Opinion Most Worth Pursuing?

Some situations make a second opinion especially useful. Consider requesting one if any of the following apply to your case.

• You have been recommended a mastectomy and want to know if breast-conserving surgery is possible.
• Your HER2 or hormone receptor result came back borderline or equivocal.
• Chemotherapy has been recommended but you have not yet had genomic testing to estimate how much benefit it may add.
• You have a less common subtype - lobular, inflammatory, or triple-negative breast cancer.
• You are considering reconstruction and want to understand all available techniques before surgery.
• Your tumor is locally advanced or has spread to lymph nodes, and you want to confirm the treatment sequence.
• You feel uncertain about the plan you have been given, for any reason.

The American Cancer Society notes that a second opinion is most valuable before a major surgical or systemic treatment decision, and that the short time needed to arrange one rarely affects outcomes in a clinically meaningful way.

What Records Do You Need to Gather?

Having the right documents ready before a second opinion saves time and produces a more complete review. Most breast cancer second-opinion specialists will want the following.

• Full pathology report from your biopsy - not just the summary letter, but the complete typed report with all values
• Original biopsy slides or a tissue block, for re-reading by a second pathologist
• Receptor testing results: ER, PR, and HER2, including IHC and ISH values where available
• Genomic test report (such as Oncotype DX or MammaPrint), if one has been completed
• All imaging reports: mammogram, ultrasound, breast MRI, and any staging scans such as a bone scan or PET-CT
• Operative reports, if surgery has already taken place
• Your current treatment plan and any medications already started
• Genetic counseling or BRCA testing results, if applicable

Can You Get a Breast Cancer Second Opinion Online?

Yes. Many cancer centers and specialist platforms now offer remote second opinions. You upload your records, a specialist reviews them, and a written opinion is usually returned within a few days. This option works well for patients who live far from a major cancer center, or who need a thorough review without the cost and delay of travel.

Memorial Sloan Kettering Cancer Center notes that a remote second opinion can be just as thorough as an in-person one when the records provided are complete. Make sure your files include everything - full pathology values and imaging files, not just summary letters.

When to Talk to Your Doctor

Talk to your oncology team if you are uncertain about any part of your diagnosis or treatment plan. This is especially important if your receptor or genomic test results came back borderline, if you are being asked to make a major surgical decision you do not yet feel settled about, or if no one has raised the question of genetic counseling. Asking for a second opinion is a normal part of breast cancer care. A team that supports your decision-making will not be troubled by the request.

You can upload your records and book an online consultation at HealthUnwired.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.